Men who started on high-efficacy DMTs had fewer relapses: Analysis
Men with multiple sclerosis (MS) who started on high-efficacy disease-modifying therapies (DMTs) experienced significantly fewer relapses than those…
Articles by Steve Bryson, PhD
Exercise in MS eases fatigue, improves muscular fitness: Analysis
Exercise effectively reduces fatigue and improves muscular fitness in people with multiple sclerosis (MS), though the optimal exercise type…
Stable MS patients free of disease activity after DMT stops: Study
About four in five adults with stable multiple sclerosis (MS) for at least five years remained free of disease…
Severe COVID-19 may double risk of MS: Swedish study
Hospitalization for severe COVID-19 is significantly associated with a twofold higher risk of developing multiple sclerosis (MS), according to…
Nerve stimulation for bladder issues also can make sex more enjoyable
Percutaneous tibial nerve stimulation (PTNS), a nonsurgical treatment that delivers mild electrical impulses to a nerve in the ankle, significantly…
Higher bile acid levels in blood linked to slower MS progression
Higher blood levels of bile acids — molecules found in the digestive fluid bile, which helps absorb fat in the…
DMTs have slowed RRMS disability progression rate: Analysis
The rate of disability progression among people with relapsing-remitting multiple sclerosis (RRMS) has slowed over the years due to…
Researchers find sulfuretin molecule may promote myelin repair
Researchers at the Oregon Health & Science University have discovered a plant-derived small molecule that can promote the growth of…
Cancer risk slightly elevated in MS patients: 10-year study
People with multiple sclerosis (MS) may have a slightly higher cancer risk than the general population, according to a…
Sublingual cladribine shown equivalent to MS treatment Mavenclad
A sublingual formulation of cladribine, which is the active ingredient of the approved oral treatment Mavenclad, in relapsing…
‘Eating Well with MS’ program improves dietary behavior: Study
An online education program called “Eating Well with MS” improved the dietary behavior of adults with multiple sclerosis (MS),…
National MS Society updates Pathways to Cures RoadmapÂ
The National Multiple Sclerosis Society (NMSS) has updated its Pathways to Cures Roadmap to account for recent scientific…
Glial cells implicated in MS disease progression, development
Glial cells, which mostly support the function of nerve cells, play key roles in multiple sclerosis (MS) disease progression…
Kesimpta outperforms Aubagio among ethnically diverse groups
Kesimpta (ofatumumab) is more effective than Aubagio (teriflunomide) among people with multiple sclerosis (MS) from ethnically diverse…
CHIT1 levels at diagnosis may predict future MS progression
Levels of the immune cell protein CHIT1 at diagnosis, taken from the spinal fluid via a spinal tap, may strongly…
Stem cell therapy leads to short-term disability reduction in MS
People with multiple sclerosis (MS) tend to experience a short-term reduction in disability and brain lesion volume after receiving…
Greater immune ‘misdirection’ against EBV found in MS: Study
People with multiple sclerosis (MS) have elevated immune responses to more proteins of the Epstein-Barr virus (EBV) than…
Balance, cardio training project aims to improve walking ability in MS
A Marquette University team is leading a new project that will combine balance and cardio training with the goal of…
Altered immune B-cell metabolism drives inflammation in MS: Study
An abnormally active metabolism in immune B-cells can trigger the release of pro-inflammatory signaling molecules that drive further inflammation in…
Use of mild-to-moderate DMTs predicts switching to other DMTs
People with multiple sclerosis (MS) who start treatment with a mild-to-moderate efficacy disease-modifying therapy (DMT) were more likely…
Interferon beta corrects gene processing disrupted in MS: Study
Alternative splicing, a biological process that allows a single gene to code for multiple proteins, is extensively disrupted in immune…
Small molecule promotes myelin sheath repair in MS mice: Study
A small molecule called ESI1 stimulated the repair of the myelin sheath, the fatty coating on nerve fibers that…
Charles River to help FibroBiologics produce 3D cell-based therapiesÂ
Charles River Laboratories has joined up with FibroBiologics to manufacture the company’s spheroids for clinical trials in…
NfL blood levels predict CIS to MS conversion: Clinical trial data
High blood levels of the nerve damage biomarker neurofilament light chain (NfL) significantly increased the risk of people with…
COVID-19 found to increase risk of hospitalization, death in MS: Study
People with multiple sclerosis (MS) in England had a seven times greater risk of hospitalization and a fourfold increased…
Worse disease severity predicts erectile dysfunction in MS men
Erectile dysfunction is more likely to occur among men with multiple sclerosis (MS) whose disease is more severe, according…
Stem cell transplant alters immune cells in MS mouse model: Study
A stem cell transplant effectively reduced the abnormal immune response that drives multiple sclerosis (MS) progression by altering…
Obesity medications linked to reduced chance of MS in real world
The use of obesity medications — approved drugs for treating diabetes and promoting weight loss — is associated with a…
KYV-101 helps 2 hard-to-treat progressive MS patients: Case study
Kyverna Therapeutics‘ cell-based therapy KYV-101 had an acceptable safety profile and promising treatment effects when given to two people…
New bilingual graphic aims to raise awareness of early MS symptoms
A bilingual graphic educational message, dubbed VISIBL-MS, has been developed by researchers at the University of Connecticut (UConn) to…